Po-Cheng Chang et al. found that valsartan/sacubitril (LCZ696) treatment increased the expression of potassium channels, including ERG, KCNE1 and KCNE2, in a rat MI-HF model [76]. The gene discussed is KCNA3; the disease is myocardial infarction.